471-54-5|Isocolumbin - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Isocolumbin | CAS:471-54-5

Isocolumbin

Name：Isocolumbin
CAS：471-54-5
Synonyms：
Molecular Formula：C₂₀H₂₂O₆
Molecular Weight：358.39
EINESC：

Description

Properties

没有数据	没有数据

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Eu3+ Sensitization via Nonradiative Interparticle Energy Transfer Using Inorganic Nanoparticles.Marie Anne van de Haar et al.The journal of physical chemistry letters, 11(3), 689-695 (2020-01-11) Spontaneous and directed symmetry breaking in the formation of chiral nanocrystals.Uri Hananel et al.Proceedings of the National Academy of Sciences of the United States of America, 116(23), 11159-11164 (2019-05-18) Elemental labelling and mass spectrometry for the specific detection of sulfenic acid groups in model peptides: a proof of concept.Mona Sharar et al.Analytical and bioanalytical chemistry, 409(8), 2015-2027 (2017-01-18) Determination of Handedness in a Single Chiral Nanocrystal via Circularly Polarized Luminescence.Eitam Vinegrad et al.ACS nano, 13(1), 601-608 (2018-12-07) Self-limiting adsorption of Eu³⁺ on the surface of rod-shape anatase TiO₂ nanocrystals and post-synthetic sensitization of the europium-based emission.Choumini Balasanthiran et al.Journal of colloid and interface science, 459, 63-69 (2015-08-12) Time-resolved fluorescence sensing of pesticides chlorpyrifos, crotoxyphos and endosulfan by the luminescent Eu(III)-8-allyl-3-carboxycoumarin probe.Hassan A Azab et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 148, 114-124 (2015-04-16)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News